92 related articles for article (PubMed ID: 3435604)
1. Effect of pirozadil on lipids, lipoproteins and apolipoproteins in Japanese with type IIa hyperlipoproteinemia.
Shinomiya M; Ishikawa Y; Shirai K; Saito Y; Yoshida S
Arzneimittelforschung; 1987 Sep; 37(9):1069-71. PubMed ID: 3435604
[TBL] [Abstract][Full Text] [Related]
2. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(12):1682-4. PubMed ID: 6686774
[TBL] [Abstract][Full Text] [Related]
3. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
5. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
[TBL] [Abstract][Full Text] [Related]
6. [Apolipoproteins A-1 and B of the blood plasma and apolipoproteins A-1 of 2 high-density lipoprotein subclasses in ischemic heart disease patients with various lipoprotein spectra].
Metel'skaia VA; Perova NV; Chernysheva NP; Kurdanov KhA; Polesskiĭ VA
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(1):83-9. PubMed ID: 6407489
[TBL] [Abstract][Full Text] [Related]
7. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
8. Effects of gamma-oryzanol on serum lipids and apolipoproteins in dyslipidemic schizophrenics receiving major tranquilizers.
Sasaki J; Takada Y; Handa K; Kusuda M; Tanabe Y; Matsunaga A; Arakawa K
Clin Ther; 1990; 12(3):263-8. PubMed ID: 1974170
[TBL] [Abstract][Full Text] [Related]
9. The effect of pirozadil on plasma lipids and lipoproteins in 1185 hyperlipidaemic subjects. Multicentre study in general practice in Spain.
Tapounet R; Marti Ragué I
Drugs Exp Clin Res; 1987; 13(7):447-50. PubMed ID: 3652931
[TBL] [Abstract][Full Text] [Related]
10. [Lipids, lipoproteins and apolipoproteins in normal newborns].
Casanueva V; Cid X; Chiang MT; Molina M; Ferrada MC; Pérez R; Casanueva P
Rev Med Chil; 1998 Sep; 126(9):1073-8. PubMed ID: 9922510
[TBL] [Abstract][Full Text] [Related]
11. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
Wechsler JG; Hutt V; Klör HU; Ditschuneit H
Artery; 1980; 8(6):519-29. PubMed ID: 7259531
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of ciprofibrate in primary type II and IV hyperlipidemia: the Italian multicenter study.
Cattin L; Da Col PG; Feruglio FS; Finazzo L; Rimondi S; Descovich G; Manzato E; Zambon S; Crepaldi G; Siepi D
Clin Ther; 1990; 12(6):482-8. PubMed ID: 2289217
[TBL] [Abstract][Full Text] [Related]
13. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
14. National Cooperative Gallstone Study: the effect of chenodeoxycholic acid on lipoproteins and apolipoproteins.
Albers JJ; Grundy SM; Cleary PA; Small DM; Lachin JM; Schoenfield LJ
Gastroenterology; 1982 Apr; 82(4):638-46. PubMed ID: 6800869
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of pirozadil, administered continuously over four and a half years, in patients with hyperlipoproteinemia type IIa].
Cuchi de la Cuesta C; Cuchi Alfaro MT; Cuchi Alfaro C
Rev Clin Esp; 1989 Jan; 184(1):24-6. PubMed ID: 2704867
[TBL] [Abstract][Full Text] [Related]
16. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia and phenotype IIa and IIB. II. Changes of lipid composition of plasma lipoprotein fractions after lovastatin administration].
Idzior-Waluś B
Przegl Lek; 1992; 49(10):327-33. PubMed ID: 1308286
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hyperlipoproteinemia type II with etofibrate.
Gustafson A
Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):498-502. PubMed ID: 528096
[TBL] [Abstract][Full Text] [Related]
18. [Effects of medium-term probucol treatment on plasma lipids and lipoproteins. 16 cases of type IIa and IIb hyperlipoproteinaemia (author's transl)].
Rouffy J; Chanu B; Bakir R; Goy-Loepper J; Saya C
Nouv Presse Med; 1980 Oct; 9(40):3014-7. PubMed ID: 7443443
[TBL] [Abstract][Full Text] [Related]
19. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
Lacourcière Y; Gagné C
J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
[TBL] [Abstract][Full Text] [Related]
20. Treatment of hyperlipoproteinemia (HLP) type II A with a new phenoxy-isobuturic acid derivative, procetofen.
Micheli H; Pometta D; Gustafson A
Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):503-6. PubMed ID: 528097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]